Digital health leader WellDoc has received FDA 510(k) class II clearance for a non-prescription version of the BlueStar® digital therapeutic diabetes management platform. This news comes on the heels of two other significant recent announcements for BlueStar®: the FDA’s clearance of the wireless integration of LifeScan’s OneTouch Verio Flex® blood glucose monitoring system with BlueStar®, and plans to incorporate the American Association of Diabetes Educators’ (AADE) curriculum in the BlueStar®
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Novo Nordisk, Glooko Team Up to Develop Digital Diabetes Solutions
Pharmaceutical company Novo Nordisk and Glooko, a remote patient monitoring platform for diabetes are teaming up to develop digital health solutions for diabetes. As part of the non-exclusive collaboration, both companies will work together to create co-branded digital health solutions that will deliver personalized, digital services to support people with diabetes in areas including treatment adherence and blood glucose management.For Novo Nordisk, the integration of these offerings within its
Read More
FDA Clears Wireless Integration of LifeScan’s OneTouch With WellDoc’s Diabetes Management Platform
The U.S. Food and Drug Administration (FDA) announced it has cleared the wireless integration of the OneTouch Verio Flex® blood glucose monitoring system with WellDoc Inc.'s clinically validated diabetes management platform, BlueStar®. The integration will create an integrated, connected experience for people with Type 2 diabetes and deliver value for healthcare providers. Integration DetailsUsing blood glucose data wirelessly and automatically transmitted from the OneTouch Verio Flex blood
Read More
Medtronic Integrates With Fitbit to Understand How Exercise Impacts Glucose Levels
Medtronic has announced a partnership with connected health provider Fitbit to integrate health and activity tracking to physicians and care teams for patients living with diabetes. With this integration, patients with Type 2 diabetes will be able to monitor their glucose levels and physical activity data via Medtronic's iPro(TM)2 myLog mobile app. Together, the partnership will provide meaningful insight on how exercise impacts glucose levels for more effective diabetes care
Read More
LMC Diabetes & Endocrinology Launch Digital Diabetes Platform for 30k Patients
LMC Diabetes & Endocrinology (LMC), the largest diabetes specialist care provider in Canada is teaming up with ViiMed to launch a digital diabetes platform for more than 30,000 patients. Delivered via telehealth and remote patient monitoring, the digital diabetes education and management program will expand access to care and help patients self-manage their condition for better outcomes. Providers can foster greater patient engagement and satisfaction, save time, and reduce operational costs
Read More
Yes Health and Solera Health Partner to Provide On-Demand Mobile Diabetes Prevention Tools
Yes Health, an all-mobile program to prevent type 2 diabetes has teamed up with Solera Health, an integrator of chronic disease prevention and management solutions to provide on-demand mobile diabetes prevention tools and resources to millions of eligible health plan members. The strategic partnership will enable qualified, at-risk patients with access to Yes Health's Centers for Disease Control and Prevention (CDC)-recognized Diabetes Prevention Program (DPP), as a covered medical benefit.Under
Read More
WellDoc, LifeScan Integrate to Create Type 2 Diabetes Management Platform
WellDoc has entered a commercial partnership agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company (JJDCC), to deliver a best-in-class digital health solution for individuals living with Type 2 diabetes. The combined offering will seek to create a comprehensive, data-driven and payer-reimbursed program for Type 2 diabetes management.WellDoc’s BlueStar® diabetes management platform and mobile app is the first digital therapeutic approved by the U.S. Food and Drug
Read More
Glooko, Diasend Merge to Create International Diabetes Management Platform
Diabetes management platform companies Diasend and Glooko announced that it will merge into one company under the Glooko name to deliver the world’s premier diabetes management platform focused on making diabetes management easier for people with diabetes and the teams who care for them. In addition to its merger, the companies have raised $8M in equity financing, led by global venture capital firm Canaan Partners, to accelerate integration and sales efforts. Other investors include Social
Read More
Google’s Verily, Sanofi Launch $500M Diabetes Joint Venture Onduo
French pharma company Sanofi and Verily Life Sciences LLC, (formerly Google Life Sciences), an Alphabet company are teaming up on a $500M joint venture named Onduo to develop a comprehensive diabetes platform. Based in Kendall Square in Cambridge, the Onduo joint venture will combine devices, software, medicine and professional care to enable simple and intelligence disease management for patients. Joshua Riff, M.D., M.B.A will serve as Onduo’s newly appointed Chief Executive Officer. As part
Read More
UT Diabetes Project Granted $3M to Develop Diabetes Management Apps
The University of Texas System’s Project Diabetes and Obesity Control (DOC) recently received $3 million from the Valley Baptist Legacy Foundation to expand its innovative diabetes management apps in the lower Rio Grande Valley. The Board of Regents approved $15 million this week to continuing funding the project to develop apps that enable patients and physicians to improve the control of diabetes and patient care.Project DOC OverviewWith Project DOC (Diabetes Obesity Control), The UT System’s
Read More
